Immunological Biomarkers Improve the Accuracy of Clinical Risk Models of Infection in the Acute Phase of Ischemic Stroke

Publisher： Karger

E-ISSN： 1421-9786|35|3|220-227

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.35, Iss.3, 2013-02, pp. : 220-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cocktail Blood Biomarkers: Prediction of Clinical Outcomes in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 69, Iss. 2, 2012-11 ,pp. : 68-75

Karger

Access to resources Recommend Favorite

Stroke-Associated Infection Is an Independent Risk Factor for Poor Outcome after Acute Ischemic Stroke: Data from the Netherlands Stroke Survey

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-03 ,pp. : 465-471

Karger

Access to resources Recommend Favorite

High-Density Lipoprotein: A Novel Marker for Risk of In-Hospital Infection in Acute Ischemic Stroke Patients?

By  

Cerebrovascular Diseases, Vol. 35, Iss. 3, 2013-04 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

Acute Ischemic Stroke and New Anticoagulants – How to Act in the Acute Phase of Stroke

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-02 ,pp. : 91-91

Karger

Access to resources Recommend Favorite

Aphasia during the Acute Phase in Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 25, Iss. 4, 2008-02 ,pp. : 316-323

Karger

Access to resources Recommend Favorite